Diseases, Conditions, Syndromes

Why isn't there a vaccine for staph?

Staph bacteria, the leading cause of potentially dangerous skin infections, are most feared for the drug-resistant strains that have become a serious threat to public health. Attempts to develop a vaccine against methicillin-resistant ...

Surgery

Over 17.7 million cosmetic procedures performed in U.S. in 2018

(HealthDay)—More than 17.7 million surgical and minimally invasive cosmetic procedures were performed in the United States in 2018, with an increasing trend seen in body-shaping procedures, according to a report published ...

Medical research

Compounds kill C. diff, don't affect other gut bacteria in vitro

NC State researchers developed a drug-testing pipeline to help identify compounds that worked against the three stages of Clostridium difficile infection, and found that a compound that holds promise for treating antibiotic-resistant ...

Diseases, Conditions, Syndromes

Supercharged 'clones' spark scarlet fever's re-emergence

A University of Queensland-led team of international researchers says supercharged "clones" of the bacteria Streptococcus pyogenes are to blame for the resurgence of the disease, which has caused high death rates for centuries.

Diseases, Conditions, Syndromes

Researchers discover potential antidote to botulism

Researchers have identified a compound that strongly inhibits botulinum neurotoxin, the most toxic compound known. That inhibiting compound, nitrophenyl psoralen (NPP), could be used as a treatment to reduce paralysis induced ...

Sports medicine & Kinesiology

Study finds tennis elbow treatments provide little to no benefit

The painful condition known as "tennis elbow" results from overuse of the tendons in the forearm, typically in a patient's dominant arm. A repetitive stress injury, tennis elbow affects not just athletes, but also tradesmen, ...

Oncology & Cancer

New therapy for HER2-positive breast cancer developed

Patients with HER2-positive breast cancer may soon have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research.

page 2 from 34